What is the outlook for Indian pharma in 2018? Analysts tend to think that it's a bit uncertain but many still feel the worst may be over. The last three fiscal years have been challenging for Indian pharma companies. The year 2015/16 saw price regulations being rung in by the pricing regulator. The next ...
Read more: Pharma 2018: Expect more M&As, USFDA reinspections in a normalised year